We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to Series A Loan Funding Agreement

23 Jul 2019 10:14

RNS Number : 4241G
Oilex Ltd
23 July 2019
 

ASX Announcement

 

23 July 2019

 

ASX: OEX

AIM: OEX

 

Amendment to Series A Loan Funding Agreement

 

Oilex Ltd (the Company) is pleased to advise that it has entered into an amendment agreement to vary the terms of its loan funding facility of A$330,000 (Amendment) entered into on 26 July 2018 (Series A Loan).

 

Pursuant to the Amendment, the loan repayment date has been extended from 26 July 2019 to 1 October 2019. In addition, the Company will issue 124,060,150 new options to the lenders at an exercise price of $0.00266. All other terms remain the same as the Series A Loan and are extended to 1 October 2019.

 

Summary of Key Terms after the Amendment

 

Term: 1 October 2019

Interest Rate: 5%

Repayments 100% payable at maturity

Options Issued: 124,060,150 options over ordinary shares

Option Exercise Price: A$0.00266 per option

Option Expiry Date: On 31 December 2019

Security: Unsecured

Key Undertakings: Not to dispose of assets having an aggregate value more than A$1 million

Not to incur any financial indebtedness more than A$50,000

Not to incur any aggregate payment or outgoing exceeding A$1 million (except for wages)

 

Customary additional provisions regarding events of default, undertakings, covenants and representations and warranties remain unchanged.

 

The options, which if exercised in their entirety, will result in a cash inflow to the Company of A$330,000. The proceeds from the conversion of options will be applied to the outstanding Series A Loan balance, which is fully drawn down.

 

The issue of the options is subject to shareholder approval under ASX Listing Rule 7.1 on or before 30 September 2019. Failure to secure shareholder approval will require immediate repayment of the loan principal and accrued interest. The Company is currently preparing the necessary notice of general meeting, which will be sent to shareholders shortly.

 

Related Party Transaction

 

Republic Investment Management Pte Ltd (Republic) makes up $300,000 of the Series A Loan balance of $330,000. Republic has a shareholding in the Company of 10.53% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, the entering into the Amendment with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the Amendment with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

For and on behalf of Oilex Ltd

 

Mark Bolton

Chief Financial Officer Company Secretary

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: mweir@citadelmagnus.com

Tel: +618 6160 4900

Australia

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLIFIADAIVFIA
Date   Source Headline
24th Oct 20169:56 amRNSQuarterly Report 30 September 2016
24th Oct 20169:08 amRNSOilex Investor Presentation October 2016
24th Oct 20168:58 amRNS2016 Annual Report to Shareholders
24th Oct 20168:33 amRNS2016 AGM Notice of Meeting and Proxy Form
24th Oct 20168:29 amRNS2016 AGM Notice of Meeting
17th Oct 20167:00 amRNSAgreement with GSPC on Cambay-78 Well
29th Sep 20169:03 amRNSAppendix 4G
29th Sep 20169:03 amRNSFinancial Report for year ended 30 June 2016
29th Sep 20168:35 amRNSOilex Corporate Update
25th Aug 20167:00 amRNSExpiry of Unlisted Options
29th Jul 20167:00 amRNSQuarterly Report 30 June 2016
28th Jun 20167:00 amRNSExpiry of Unlisted Options
27th Jun 20167:00 amRNSOilex Investor Presentation June 2016
24th Jun 201610:48 amRNSOilex Corporate Update
10th Jun 201610:17 amRNSAppointment of CFO
8th Jun 20167:00 amRNSZeta Legal Proceedings Settlement
24th May 20168:09 amRNSExecutive Management Changes
18th May 20167:00 amRNSNotification of Major Interest in Shares
17th May 20167:21 amRNSNotification of Major Interest in Shares
6th May 20167:00 amRNSCancellation of Unlisted Options
29th Apr 20168:39 amRNSQuarterly Report 31 March 2016
8th Apr 20167:00 amRNSCommencement of Gas Production from Bhandut Field
18th Mar 20167:00 amRNSOilex Appoints New MD - Jonathan Salomon
18th Mar 20167:00 amRNSAppendix 3Z R Miller
14th Mar 20167:00 amRNSInterim Report 31 December 2015
8th Mar 20167:00 amRNSExpiry of Unlisted Options
1st Mar 20167:00 amRNSZeta Legal Proceedings Update
11th Feb 20167:00 amRNSOilex Strengthens Board with Appointment of NED
11th Feb 20167:00 amRNSAppendix 3X B Lingo
29th Jan 20167:00 amRNSQuarterly Report 31 December 2015
6th Jan 20167:00 amRNSExpiry of Unlisted Options
21st Dec 20157:00 amRNSIndia Operations Update
18th Dec 20157:00 amRNSZeta Legal Proceedings Update
8th Dec 20157:00 amRNSCambay Workover Update
2nd Dec 20159:40 amRNSZeta Legal Proceedings Update
1st Dec 20157:00 amRNSAppendix 3X J Salomon
30th Nov 20157:00 amRNSDirector Appointment
26th Nov 201510:37 amRNSASX Trading Halt
25th Nov 20157:40 amRNSAppendix 3Z J Auld
25th Nov 20157:35 amRNSAppendix 3Z S Bhandari
25th Nov 20157:32 amRNSResults of Annual General Meeting 25 November 2015
25th Nov 20157:00 amRNSCorporate Presentation November 2015
25th Nov 20157:00 amRNSChairman's Address to Shareholders
20th Nov 201512:58 pmRNSAppendix 3Y - S Bhandari
18th Nov 20153:00 pmRNSWithdrawal of Resolution
17th Nov 20151:50 pmRNSIndia Workover Update
13th Nov 20151:00 pmRNSEnd of Trading Halt on ASX
13th Nov 20158:23 amRNSUK Broker
12th Nov 20151:10 pmRNSZeta Update and Legal Proceedings
12th Nov 20157:00 amRNSTrading Halt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.